Difference between revisions of "Main Page"
m (→Documents) |
|||
| Line 24: | Line 24: | ||
:* [[Volumetric-CT tech ctte]] | :* [[Volumetric-CT tech ctte]] | ||
:* [[COPD-Asthma tech ctte]] | :* [[COPD-Asthma tech ctte]] | ||
| + | |||
| + | QIBA also has one active Ad Hoc committee: | ||
| + | :*[[Committee on Open Image Archives]] | ||
==Public Comment Documents== | ==Public Comment Documents== | ||
| − | + | Documents published by QIBA for public comment can be found here: | |
:*[[Work Product for Review]] | :*[[Work Product for Review]] | ||
==Documents== | ==Documents== | ||
| + | <<We should probably move these documents off the front page onto more topic oriented pages, and explain what they contain/what they are for>> | ||
*[[Media:Guidance Standards for CTs.pdf|Guidance Standards for CTs]] | *[[Media:Guidance Standards for CTs.pdf|Guidance Standards for CTs]] | ||
| Line 57: | Line 61: | ||
*[[Media:Oncology section.ppt|Oncology section from 2009 Imaging Biomarkers Roundtable]] | *[[Media:Oncology section.ppt|Oncology section from 2009 Imaging Biomarkers Roundtable]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
==Quantitative Imaging/Imaging Biomarkers and QIBA Meetings and Activities== | ==Quantitative Imaging/Imaging Biomarkers and QIBA Meetings and Activities== | ||
Revision as of 01:46, 8 December 2011
This Wiki is for collaborative creation of QIBA materials and ongoing activities.
Quantitative Imaging Biomarkers Alliance (QIBA)
QIBA Mission: Improve the value and practicality of quantitative biomarkers by reducing variability across devices, patients and time.
QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry . This involves:
- collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time.
- accelerating the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.
QIBA develops Profile specifications and coordinates the necessary research and qualification groundwork.
QIBA Committees
QIBA currently has five active technical committees:
QIBA also has one active Ad Hoc committee:
Public Comment Documents
Documents published by QIBA for public comment can be found here:
Documents
<<We should probably move these documents off the front page onto more topic oriented pages, and explain what they contain/what they are for>>
- HHSN268201000050C QIBA (NIBIB) Annual Progress Report September 2011
- HHSN268201000050C QIBA (NIBIB) SemiAnnual Progress Report March 2011
- HHSN268201000050C QIBA (NIBIB) Proposed Work Plan November 2010
- HHSN268201000050C QIBA (NIBIB) Proposed Methodology October 2010
- HHSN268201000050C QIBA (NIBIB) Round-1 Funded Projects Overview
- "Why QIBA?" - Specifics associated with CT device and software manufacturers.
- "Why QIBA?" - Specifics associated with PET-CT device and software manufacturers.
- "Why QIBA?" - Specifics associated with MR device and software manufacturers.
- QIBA posters and plenary session presentation from RSNA 2011 Annual Meeting
- QIBA and UPICT posters from RSNA 2010 Annual Meeting
- QIBA and UPICT posters from RSNA 2009 Annual Meeting
- QIBA posters from RSNA 2008 Annual Meeting
- EMEA Guideline on Clinical Evaluation of Diagnostic Agents (2009.08.04)
- EMEA Guideline - Appendix 1 (2009.08.04)
- Oncology section from 2009 Imaging Biomarkers Roundtable
Quantitative Imaging/Imaging Biomarkers and QIBA Meetings and Activities
- QI/IB Special Interest Session-
Imaging Biomarkers for Clinical Care and Research Monday, November 29, 2010 Presentations
- QIBA Annual Meeting Presentations
May 24-25, 2011 Renaissance Arlington Capital View, Arlington VA Presentations
NEW: "How To" help pages
<This Wiki is a Work In Progress: read Help, create an account, contribute>